3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Breast Neoplasms
20
Pain, Postoperative
5
Stomach Neoplasms
4
Pancreatic Neoplasms
4
Neoplasms
4
Lung Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Brain Neoplasms
4
Prostatic Neoplasms
3
Myoma
3
Leiomyoma
3
Head and Neck Neoplasms
3
Glioblastoma
3
Colorectal Neoplasms
3
Agnosia
3
Stomatitis
2
Skin Neoplasms
2
Postoperative Hemorrhage
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Melanoma
2
Lymphoma, Non-Hodgkin
2
Hemorrhage
2
Fatigue
2
Colonic Neoplasms
2
Chronic Pain
2
Carcinoma, Hepatocellular
2
Water-Electrolyte Imbalance
1
Vulvodynia
1
Uterine Cervical Neoplasms
1
Interventions
Temozolomide
88
Bevacizumab
49
Radiotherapy
36
Irinotecan
22
Magnetic Resonance Spectroscopy
21
Surgical Procedures, Operative
17
Carboplatin
17
Carmustine
15
Radiation
13
Nivolumab
11
IL13-PE38
8
Erlotinib Hydrochloride
8
Thalidomide
7
Radiotherapy, Intensity-Modulated
7
Lomustine
7
Imatinib Mesylate
7
Everolimus
7
Aminolevulinic Acid
7
sargramostim
6
Topotecan
6
O(6)-benzylguanine
6
Cyclophosphamide
6
Chemotherapy, Adjuvant
6
vandetanib
5
temsirolimus
5
fluorodopa F 18
5
Vincristine
5
Surveys and Questionnaires
5
Radiosurgery
5
Flucytosine
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Glioma
×
Sodium Chloride
×
Clear all
NCT02465268
2025-01-14
ATTAC-II
University of Florida
Phase 2
Completed
175 enrolled
18 charts